Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Brooks

Showing results (31-40 of 149) with videos related to

Pageof 15
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 11, 1992
Effect of captopril and the nonpeptide angiotensin II antagonists, SK&F 108566 and EXP3174, on renal function in dogs with a renal artery stenosisD P Brooks, P D DePalma, R R Ruffolo
British Journal of Pharmacology|May 1, 1990
Vasopressin and the pathogenesis of chronic renal failureD P Brooks, H A Solleveld, L C Contino
Expert Opinion on Investigational Drugs|July 5, 2005
Pharmacology of the angiotensin II receptor antagonist, eprosartanR M Edwards, R R Ruffolo, D P Brooks
Analytical Biochemistry|February 1, 1990
Determination of methylguanidine in plasma and urine by high-performance liquid chromatography with fluorescence detection following postcolumn derivatizationV K Boppana, G R Rhodes, D P Brooks
The Journal of Physiology|February 1, 1977
The half-life of angiotensin II analogues in the rat, determined from the decay of the pressor response [proceedings]D P Brooks, B J Chapman, K A Munday
The Journal of Physiology|February 1, 1979
The effect of meclofenamate on the natriuretic and antinatriuretic actions of angiotensin II [proceedings]D P Brooks, B J Chapman, K A Munday
Neuropeptides|December 1, 1995
Identification of ETB receptor subtypes using linear and truncated analogs of ETP Nambi, M Pullen, D P Brooks, et al.
American Heart Journal|September 1, 1999
Pharmacology of eprosartan, an angiotensin II receptor antagonist: exploring hypotheses from clinical dataD P Brooks, E H Ohlstein, R R Ruffolo
The Journal of Pharmacology and Experimental Therapeutics|August 11, 1990
Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopamD P Brooks, D J Drutz, R R Ruffolo
European Journal of Pharmacology|June 4, 1999
SB203580 reverses adrenomedullin's effect on proliferation and apoptosis in cultured mesangial cellsN Parameswaran, W S Spielman, D P Brooks, et al.
Pageof 15

Showing results (31-40 of 149) with videos related to

Sort By:
Pageof 15
The Journal of Pharmacology and Experimental Therapeutics|November 11, 1992
Effect of captopril and the nonpeptide angiotensin II antagonists, SK&F 108566 and EXP3174, on renal function in dogs with a renal artery stenosisD P Brooks, P D DePalma, R R Ruffolo
British Journal of Pharmacology|May 1, 1990
Vasopressin and the pathogenesis of chronic renal failureD P Brooks, H A Solleveld, L C Contino
Expert Opinion on Investigational Drugs|July 5, 2005
Pharmacology of the angiotensin II receptor antagonist, eprosartanR M Edwards, R R Ruffolo, D P Brooks
Analytical Biochemistry|February 1, 1990
Determination of methylguanidine in plasma and urine by high-performance liquid chromatography with fluorescence detection following postcolumn derivatizationV K Boppana, G R Rhodes, D P Brooks
The Journal of Physiology|February 1, 1977
The half-life of angiotensin II analogues in the rat, determined from the decay of the pressor response [proceedings]D P Brooks, B J Chapman, K A Munday
The Journal of Physiology|February 1, 1979
The effect of meclofenamate on the natriuretic and antinatriuretic actions of angiotensin II [proceedings]D P Brooks, B J Chapman, K A Munday
Neuropeptides|December 1, 1995
Identification of ETB receptor subtypes using linear and truncated analogs of ETP Nambi, M Pullen, D P Brooks, et al.
American Heart Journal|September 1, 1999
Pharmacology of eprosartan, an angiotensin II receptor antagonist: exploring hypotheses from clinical dataD P Brooks, E H Ohlstein, R R Ruffolo
The Journal of Pharmacology and Experimental Therapeutics|August 11, 1990
Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopamD P Brooks, D J Drutz, R R Ruffolo
European Journal of Pharmacology|June 4, 1999
SB203580 reverses adrenomedullin's effect on proliferation and apoptosis in cultured mesangial cellsN Parameswaran, W S Spielman, D P Brooks, et al.
Pageof 15